Clinical trial
Comparing Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment
NCT03899233 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment
- Lead sponsor
- Cairo University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 1, 2019
- Completion date
- November 1, 2019
- Enrollment
- 25 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
melasma